Summit Global Investments’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,600	Closed	-$564K	–	268
2018 Q3	$564K	Buy	6,600 +500	+8%	+$42.7K	0.08%	237
2018 Q2	$707K	Buy	+6,100	New	+$707K	0.11%	141